Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

XLRN

Acceleron Pharma (XLRN)

Acceleron Pharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:XLRN
FechaHoraFuenteTítuloSímboloCompañía
27/09/201615:01Business WireAcceleron Announces Retirement of John Knopf as President and CEO; Habib Dable Named as SuccessorNASDAQ:XLRNAcceleron Pharma Inc
23/09/201616:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
12/09/201615:47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XLRNAcceleron Pharma Inc
31/08/201606:00Business WireAcceleron to Participate in Three Healthcare Investor Conferences in SeptemberNASDAQ:XLRNAcceleron Pharma Inc
08/08/201614:50Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:XLRNAcceleron Pharma Inc
04/08/201616:05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XLRNAcceleron Pharma Inc
04/08/201606:00Business WireAcceleron Pharma Reports Second Quarter 2016 Financial and Operational ResultsNASDAQ:XLRNAcceleron Pharma Inc
28/07/201606:00Business WireAcceleron Pharma to Webcast Conference Call of Second Quarter 2016 Financial Results on August 4, 2016NASDAQ:XLRNAcceleron Pharma Inc
25/07/201616:05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:XLRNAcceleron Pharma Inc
25/07/201615:05Business WireAcceleron Pharma Appoints Thomas McCourt to its Board of DirectorsNASDAQ:XLRNAcceleron Pharma Inc
08/07/201606:00Business WireAcceleron Announces ACE-083 Phase 1 Results at the 14th International Congress on Neuromuscular DiseasesNASDAQ:XLRNAcceleron Pharma Inc
29/06/201606:00Business WireAcceleron Announces Presentation of ACE-083 Phase 1 Healthy Volunteer Data at the 14th International Congress on Neuromuscula...NASDAQ:XLRNAcceleron Pharma Inc
10/06/201606:00Business WireAcceleron & Celgene Announce Updated Results from an Ongoing Phase 2 Study of Luspatercept in Myelodysplastic Syndromes at th...NASDAQ:XLRNAcceleron Pharma Inc
10/06/201606:00Business WireAcceleron & Celgene Announce Updated Results from an Ongoing Phase 2 Study of Luspatercept in Beta-Thalassemia Presented at t...NASDAQ:XLRNAcceleron Pharma Inc
07/06/201615:00Business WireAcceleron Pharma to Host Conference Call & Webcast to Review Updated Luspatercept Results Presented at the 21st Congress of t...NASDAQ:XLRNAcceleron Pharma Inc
06/06/201615:41Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:XLRNAcceleron Pharma Inc
01/06/201606:00Business WireAcceleron Pharma to Participate in Two Healthcare Investor Conferences in JuneNASDAQ:XLRNAcceleron Pharma Inc
19/05/201606:00Business WireAcceleron Announces Data Presentations with Luspatercept at the 21st Congress of the European Hematology AssociationNASDAQ:XLRNAcceleron Pharma Inc
05/05/201606:00Business WireAcceleron Pharma Reports First Quarter 2016 Financial and Operational ResultsNASDAQ:XLRNAcceleron Pharma Inc
28/04/201615:05Business WireAcceleron Pharma to Host First Quarter 2016 Financial ResultsNASDAQ:XLRNAcceleron Pharma Inc
26/04/201615:30Business WireAcceleron Pharma to Participate in Two Healthcare Investor Conferences in MayNASDAQ:XLRNAcceleron Pharma Inc
15/04/201615:07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:XLRNAcceleron Pharma Inc
15/04/201615:04Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:XLRNAcceleron Pharma Inc
01/03/201606:00Business WireAcceleron Pharma to Participate in Four Healthcare Investor Conferences in MarchNASDAQ:XLRNAcceleron Pharma Inc
25/02/201606:00Business WireAcceleron Pharma Reports Fourth Quarter and Year Ended 2015 Financial and Operational Results and Recent HighlightsNASDAQ:XLRNAcceleron Pharma Inc
18/02/201606:00Business WireAcceleron Pharma to Host Fourth Quarter and Year Ended 2015 Financial ResultsNASDAQ:XLRNAcceleron Pharma Inc
16/02/201610:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:XLRNAcceleron Pharma Inc
01/02/201606:00Business WireAcceleron Pharma to Participate in Two Healthcare Investor Conferences in FebruaryNASDAQ:XLRNAcceleron Pharma Inc
11/01/201615:18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:XLRNAcceleron Pharma Inc
06/01/201615:13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:XLRNAcceleron Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:XLRN

Su Consulta Reciente

Delayed Upgrade Clock